| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Motilal Oswal Nifty MidSmall Healthcare Index Fund (G) Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.39 |
| Equity |
99.61 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
41.70% |
| Top 10 Holdings |
61.62% |
| Top 25 Holdings |
94.01% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
61.92 |
| Healthcare |
37.69 |
| Cash |
0.39 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.79 |
| PE Ratio |
38.72 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Max Healthcare Institute Limited |
14.81 |
| Lupin Limited |
9.43 |
| Fortis Health Care Ltd |
6.27 |
| Aurobindo Pharma Limited |
6.15 |
| Alkem Laboratories Limited |
5.04 |
| MANKIND PHARMA LIMITED |
4.75 |
| Laurus Labs Limited |
4.32 |
| Glenmark Pharmaceuticals Limited |
4.11 |
| IPCA Laboratories Limited |
3.68 |
| Biocon Limited |
3.06 |
| Krishna Inst of Medical Sciences Ltd. |
2.81 |
| Piramal Pharma Limited |
2.70 |
| Syngene International Limited |
2.53 |
| Suven Pharmaceuticals Limited |
2.51 |
| Abbott India Limited |
2.49 |
| J B Chemicals and Pharma Ltd |
2.37 |
| Gland Pharma Limited |
2.28 |
| Ajanta Pharma Limited |
2.13 |
| Aster DM Healthcare Limited |
2.02 |
| Dr Lal Path Labs Ltd |
2.00 |
| Natco Pharma Limited |
1.97 |
| Narayana Hrudalaya Ltd |
1.77 |
| Poly Medicure Limited |
1.66 |
| EQ- GLOBAL HEALTH LTD. |
1.62 |
| Glaxosmithkline Pharma Ltd |
1.53 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
